Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility

Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility – the second location for the privately held, New Jersey-headquartered customized clinical packaging provider.

blue-plus Continue Reading

Eric Roncskevitz Receives ASQ Quality Auditor Certification

Xerimis Inc. is pleased to announce that Eric Roncskevitz, Vice President of Technical Services, has completed the requirements to be named an ASQ-Certified Quality Auditor, or ASQ CQA.

blue-plus Continue Reading
EventNovember 30 – December 1, 2016

Xerimis to exhibit at Clinical Trial Supply-East Asia / Exhibit

This event runs from November 30 – December 1, 2016, in Seoul, Korea. Visit Xerimis at Booth #19.

blue-plus Continue Reading Seoul, Korea

Xerimis Increases Capabilities with Cutting-edge Technology

With over 40 years of experience, Dr. Peter Bernardo has been instrumental in initiating and accommodating tremendous changes in the pharmaceutical industry.

blue-plus Continue Reading

Xerimis Expands Controlled Substances Capabilites

Xerimis Inc. has been approved by the DEA as a registered distributor of schedule 3 through 5 controlled substances.

blue-plus Continue Reading
123